1. Home
  2. CRMD vs MSBI Comparison

CRMD vs MSBI Comparison

Compare CRMD & MSBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMD
  • MSBI
  • Stock Information
  • Founded
  • CRMD 2006
  • MSBI 1881
  • Country
  • CRMD United States
  • MSBI United States
  • Employees
  • CRMD N/A
  • MSBI N/A
  • Industry
  • CRMD Biotechnology: Pharmaceutical Preparations
  • MSBI Major Banks
  • Sector
  • CRMD Health Care
  • MSBI Finance
  • Exchange
  • CRMD Nasdaq
  • MSBI Nasdaq
  • Market Cap
  • CRMD 464.7M
  • MSBI 437.3M
  • IPO Year
  • CRMD 2010
  • MSBI 2016
  • Fundamental
  • Price
  • CRMD $11.63
  • MSBI $18.77
  • Analyst Decision
  • CRMD Strong Buy
  • MSBI Hold
  • Analyst Count
  • CRMD 6
  • MSBI 3
  • Target Price
  • CRMD $15.00
  • MSBI $21.33
  • AVG Volume (30 Days)
  • CRMD 2.3M
  • MSBI 124.2K
  • Earning Date
  • CRMD 05-06-2025
  • MSBI 04-30-2025
  • Dividend Yield
  • CRMD N/A
  • MSBI 6.60%
  • EPS Growth
  • CRMD N/A
  • MSBI N/A
  • EPS
  • CRMD 0.28
  • MSBI N/A
  • Revenue
  • CRMD $82,553,827.00
  • MSBI $174,721,000.00
  • Revenue This Year
  • CRMD $207.65
  • MSBI $83.04
  • Revenue Next Year
  • CRMD $50.13
  • MSBI $0.85
  • P/E Ratio
  • CRMD $41.90
  • MSBI N/A
  • Revenue Growth
  • CRMD N/A
  • MSBI N/A
  • 52 Week Low
  • CRMD $3.61
  • MSBI $14.79
  • 52 Week High
  • CRMD $13.85
  • MSBI $28.08
  • Technical
  • Relative Strength Index (RSI)
  • CRMD 69.76
  • MSBI 66.71
  • Support Level
  • CRMD $11.21
  • MSBI $17.56
  • Resistance Level
  • CRMD $12.31
  • MSBI $18.97
  • Average True Range (ATR)
  • CRMD 0.67
  • MSBI 0.47
  • MACD
  • CRMD 0.32
  • MSBI 0.26
  • Stochastic Oscillator
  • CRMD 82.29
  • MSBI 93.29

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment which generates the majority of the revenue, provides a wide range of financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage and other consumer loan products; commercial equipment financing etc. The Wealth Management segment consists of trust and fiduciary services, brokerage and retirement planning services. The Other segment includes the operating results of the parent company.

Share on Social Networks: